Gruppo Healthcare ITEL | Ruvo di Puglia is at the forefront of the future of oncology care with their revolutionary proton therapy technology. As the pioneers of ERHA, LinearBeam's proton therapy treatment, they offer a cutting-edge solution for cancer treatment. Proton therapy is considered the most advanced form of radiation therapy available today, offering minimal or no acute and late side effects, greater radiobiological effectiveness, and lower toxicity on healthy tissues.

With ERHA, the dose is precisely delivered only to the tumor mass, ensuring maximum efficacy. Gruppo Healthcare ITEL | Ruvo di Puglia specializes in treating various cancers, including brain tumors, salivary gland tumors, prostate cancer, pancreatic cancer, liver tumors, and more. Their proton therapy facility layout proposal provides a comprehensive solution for these conditions.

What sets ERHA apart is its real-time control of the linear accelerator with energy and intensity modulation, a robotic patient positioning system, and integrated control software for treatment planning. This state-of-the-art system offers superior precision and effectiveness. Choose ERHA for enhanced radiotherapy with hadrons, as it is not only cost-effective but also environmentally friendly.

It has minimal radiation and disposal issues, requiring less space and providing ease of allocation. The management of ERHA is simple for operators, with fewer components and a user-friendly software interface. Contact Gruppo Healthcare ITEL | Ruvo di Puglia today to learn more about their groundbreaking proton therapy technology and how it can transform cancer treatment